Impact of Treatment for Opioid Dependence on Fatal Drug-Related Poisoning: A National Cohort Study in England
AIMS:
To compare
the change in illicit opioid users' risk of fatal drug-related poisoning (DRP)
associated with opioid agonist pharmacotherapy (OAP) and psychological support,
and investigate the modifying effect of patient characteristics, criminal
justice system (CJS) referral, and treatment completion.
DESIGN:
National
data linkage cohort study of the English National Drug Treatment Monitoring
System and the Office for National Statistics national mortality database. Data
were analysed using survival methods.
SETTING:
All
services in England that provide publicly-funded, structured, treatment for
illicit opioid users.
PARTICIPANTS:
Adults
treated for opioid dependence during April 2005 to March 2009: 151,983
individuals; 69% male; median age 32.6 with 442,950 person-years of observation.
MEASUREMENTS:
The
outcome was fatal DRP occurring during periods in or out of treatment, with
adjustment for age, gender, substances used, injecting status, and CJS referral.
FINDINGS:
There
were 1,499 DRP deaths (3.4 per 1,000 person-years). DRP risk
increased while patients were not enrolled in any treatment. Risk when enrolled only in a psychological
intervention was double that during OAP. The
increased risk when out of treatment was greater for men, illicit drug injectors, and those
reporting problematic alcohol use.
CONCLUSIONS:
Patients
who received only psychological support for opioid dependence in England appear
to be at greater risk of fatal opioid poisoning than those who received opioid
agonist pharmacotherapy.
- 1Institute of Brain Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, UK.
- 2Institute of Population Health, Faculty of Medical and Human Sciences, University of Manchester, UK.
- 3MRC Biostatistics Unit, Cambridge, UK.
- 4School of Social and Community Medicine, University of Bristol, UK.
- 5Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
No comments:
Post a Comment